How polysubstance abuse is worsening the American opioid crisis
Studies are showing that more Americans are struggling with dependency on multiple substances.
America's addiction crisis is being ushered into a dangerous new era by rising levels of polysubstance abuse, as more people become addicted to deadly combinations of synthetic opioids and stimulants. The alarming trend is causing concern among addiction specialists and medical professionals, who say the rise of polysubstance abuse is making it harder to treat opioid addiction and taking the crisis to a new, more perilous level.
What is polysubstance abuse?
Polysubstance abuse is described by the U.S. Centers for Disease Control and Prevention (CDC) as the "use of more than one drug." This includes when multiple drugs are taken at the same time or "within a short time period," the CDC explained, "either intentionally or unintentionally." When done intentionally, polysubstance use typically occurs when someone "takes a drug to increase or decrease the effects of a different drug or wants to experience the effects of the combination," the CDC added. Unintentional use happens when someone unknowingly takes drugs that were cut or mixed with other drugs. Either way, the consequences can be deadly because the effects from a combination of drugs "may be stronger and more unpredictable than one drug alone."
Mixing substances is never safe, but combining drugs from opposite drug classes can be especially deadly. Contrary to what some substance users believe, mixing stimulants and depressants "doesn’t balance or cancel them out," the CDC said. "In fact, the results of combining drugs are unpredictable, often modifying or even masking the effects of one or both drugs." This could create the illusion that "the drugs are not affecting you, making it easier to overdose," the agency added.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
How are stimulants further complicating America's opioid crisis?
The country is in "a new and perilous period in its battle against illicit drugs," Jan Hoffman wrote for The New York Times. The scourge is "not only opioids" like fentanyl, but the rising tide of polysubstance abuse, Hoffman noted. Multiple recent studies of opioid addicts have shown that between 70 and 80% also take other substances. This is "stymieing treatment efforts and confounding state, local and federal policies," Hoffman explained.
"It’s no longer an opioid epidemic," Dr. Cara Poland, associate professor at Michigan State University's College of Human Medicine, told the Times. "This is an addiction crisis."
Non-opioids being taken alongside drugs like fentanyl and heroin include animal tranquilizer xylazine, known as tranq dope, prescription pills like Valium and Klonopin and illicit stimulants like cocaine and meth. None of these drugs are safe to mix with opioids, but the "incursion of meth has been particularly problematic," Hoffman reported. Unlike opiates, no medicines are approved to treat meth addiction, which can "undercut the effectiveness of opioid addiction therapies."
"Treating someone for opiates is relatively easy," Dr. Paul Trowbridge, an addiction medicine specialist, told the Times, but meth is a "monster." There are federally approved medications like buprenorphine and methadone that have been shown to subdue opioid cravings, as well as Narcan, the over-the-counter nasal spray for reversing opioid overdoses. While there aren't any similar treatments approved for stimulant abuse, the Food and Drug Administration has issued draft guidelines for developing therapies for stimulant-use disorders. For example, some doctors have prescribed Adderall to help patients cut back on using meth, per the Times, but "that avenue is narrowing because of the drug’s nationwide shortage," Hoffman said.
Combining deadly stimulants like cocaine and meth with "highly potent synthetic opioids" like fentanyl has become "a fast-growing driver of fatal overdoses in the U.S.," NPR reported. Deaths involving fentanyl and stimulants increased from 0.6% of total overdose deaths in 2010 to 32% as of 2021, per a study recently published in the scientific journal Addiction.
The use of fentanyl alongside stimulants is "rapidly becoming the dominant force in the U.S. overdose crisis," Joseph Friedman, the study's lead author and a researcher at UCLA's David Geffen School of Medicine, told NPR. The synthetic opioid has "ushered in a polysubstance overdose crisis." The authors called the recent spike in these overdoses the fourth wave of the US opioid crisis. Prescription opioids preceded this wave in the early 2000s, heroin in the early 2010s and "fentanyl circa 2013," NPR summarized.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Theara Coleman has worked as a staff writer at The Week since September 2022. She frequently writes about technology, education, literature and general news. She was previously a contributing writer and assistant editor at Honeysuckle Magazine, where she covered racial politics and cannabis industry news.
-
Today's political cartoons - December 21, 2024
Cartoons Saturday's cartoons - losing it, pedal to the metal, and more
By The Week US Published
-
Three fun, festive activities to make the magic happen this Christmas Day
Inspire your children to help set the table, stage a pantomime and write thank-you letters this Christmas!
By The Week Junior Published
-
The best books of 2024 to give this Christmas
The Week Recommends From Percival Everett to Rachel Clarke these are the critics' favourite books from 2024
By The Week UK Published
-
Drugmakers paid pharmacy benefit managers to avoid restricting opioid prescriptions
Under the radar The middlemen and gatekeepers of insurance coverage have been pocketing money in exchange for working with Big Pharma
By Theara Coleman, The Week US Published
-
The future of fluoridated water is up for debate
The Explainer The oral benefits are watery
By Devika Rao, The Week US Published
-
Polycystic ovary syndrome: what it is, how it's treated and why it's often misunderstood
The Explainer PCOS affects millions, but there is still no cure outside of treating symptoms separately
By Theara Coleman, The Week US Published
-
The growing list of conditions weight-loss drugs could help with
The Explainer Ozempic and similar drugs have been linked to possibly helping diseases beyond diabetes and obesity. Are they miracle drugs?
By Theara Coleman, The Week US Published
-
ADHD drugs shortage: what's behind it?
The Explainer Supply chain issues and 'tripling' of prescriptions concerns GPs as problems getting medication become 'desperate'
By The Week UK Published
-
Should blood donors be paid?
The Explainer Financial rewards would help fill NHS shortfall but bring risk of contamination and exploitation, WHO warns
By The Week UK Published
-
Cannabinoid hyperemesis syndrome: a rare but troubling health risk for cannabis users
The Explainer The illness is sending some chronic marijuana users to emergency care for painful persistent vomiting
By Theara Coleman, The Week US Published
-
Pink cocaine: the new drug cocktail responsible for an increasing number of deaths
In the Spotlight The substance has been linked to the death of Liam Payne and named in a lawsuit against Sean 'Diddy' Combs
By Justin Klawans, The Week US Published